Proposed OneAlbany - NYOH Regional Cancer Center

Project Background

The applicant, Columbia Development Companies, filed a Special Use Permit application for a proposed $55 million-dollar, state-of-the-art Regional Cancer Center located on 8.36 acres of land in the Transit Oriented Development (TOD) District at 4 Crossgates Mall Road, Guilderland, New York. The 120,000 square foot, three (3) story facility, will be occupied by New York Oncology Hematology (“NYOH”). The parcel fronts Crossgates Mall Road and access to the site will be provided from Gabriel Terrace and New Lehner Road. The proposed use requires a minimum of 760 parking spaces and the applicant is proposing to install 600 parking spaces, which includes 25 accessible parking spaces. The applicant filed an area variance requesting a reduction in parking. 

NYOH is the region’s largest provider of cancer and blood disorder treatments. The new Regional Cancer Center will include radiation treatment, chemotherapy and comprehensive cancer care. It will also have a prescription pharmacy with a drive through lane, serenity garden, and picnic area. Providers will see patients on a scheduled basis. The Hours of Operation shall be Monday through Saturday from 7:00am to 7:00pm. The facility will have 275 employees and will receive the following types of deliveries: medical supplies, medications (intravenous/oral), general supplies and radiopharmaceuticals. 

Special Use Permit Review Process

The proposed OneAlbany - NYOH Regional Cancer Center requires approval of a Special Use Permit (SUP) by the Zoning Board of Appeals (ZBA). Pursuant to Section 280-52.B of Town Code, the ZBA is the lead agency for reviews of SUP's having the authority to permit the use. The first step in the review of SUP's is for the Planning Board to conduct a site plan review and provide a report to the ZBA pursuant to Section 280-52.C of Town Code. The Planning Board will commence their review of the site plan in January 2024.

Environmental Impact Statement

In August 2020 the Planning Board adopted the Environmental Impact Findings Statement for the Rapp Road Residential/Western Avenue Mixed Use Redevelopment Projects, which analyzed the following three sites:

Site 1 - Development of 222 one- and two-bedroom apartments on a ±19 acre site. Construction of the apartments (Apex at Crossgates) has commenced with the first phase anticipated to be completed May 2024.

Site 2 - Development of ±160,000 square feet Costco retail use with associated fueling facility located on ±16 acres. Special Use Permit approved May 2023.

Site 3 - Conceptual development of ±115,000 SF of retail, 50,000 SF of office space, and 48 apartments on 11.34 acres. Proposed OneAlbany - NYOH Regional Cancer Center Site.

Adoption of the Environmental Impact Statement was the culmination of over a year-long process assessing and analyzing environmental concerns and proposing measures to mitigate those concerns to the maximum extent practicable. Adoption of the Findings Statement by the Planning Board completed the State Environmental Quality Review Environmental Impact Statement process.

Click the link for the Environmental Impact Statement webpage and more detailed information:

View the Environmental Impact Statement page regarding Rapp Road Residential/Western Avenue Mixed-Use Redevelopment Projects.